Tempol, a Superoxide Dismutase Mimetic Agent, Inhibits Superoxide Anion-Induced Inflammatory Pain in Mice
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
The present study evaluated the anti-inflammatory and analgesic effects of the superoxide dismutase mimetic agent tempol in superoxide anion-induced pain and inflammation. Mice were treated intraperitoneally with tempol (10–100 mg/kg) 40 min before the intraplantar injection of a superoxide anion donor, potassium superoxide (KO 2, 30 μ g). Mechanical hyperalgesia and thermal hyperalgesia, paw edema, and mRNA expression of peripheral and spinal cord mediators involved in inflammatory pain, TNF α, IL-1 β, IL-10, COX-2, preproET-1, gp91phox, Nrf2, GFAP, and Iba-1, were evaluated. Peripheral and spinal cord reductions of antioxidant defenses and superoxide anion were also assessed. Tempol reduced KO 2-induced mechanical hyperalgesia and thermal hyperalgesia and paw edema. The increased mRNA expression of the evaluated mediators and oxidative stress in the paw skin and spinal cord and increased mRNA expression of glial markers in the spinal cord induced by KO 2 were successfully inhibited by tempol. KO 2-induced reduction in Nrf2 mRNA expression in paw skin and spinal cord was also reverted by tempol. Corroborating the effect of tempol in the KO 2 model, tempol also inhibited carrageenan and CFA inflammatory hyperalgesia. The present study demonstrates that tempol inhibits superoxide anion-induced molecular and behavioral alterations, indicating that tempol deserves further preclinical studies as a promising analgesic and anti-inflammatory molecule for the treatment of inflammatory pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Tempol inhibits KO2-induced hyperalgesia and paw edema. Mice were treated with tempol (10–100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Nociceptive thresholds to mechanical (a) and thermal (b) stimuli as well as paw edema (c) were measured 1–5 h after KO2 injection. Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle; ∗∗p < 0.05 versus KO2 + tempol 10 mg/kg; ##p < 0.05 versus KO2 + tempol 30 mg/kg (ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/40a2cf62c8a94a8d80cd33deb8e5e142/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-1.jpg)
![Figure 2 Tempol inhibits KO2-induced TNFα, IL-1β, and IL-10 mRNA expression in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and TNFα ((a) and (b)), IL-1β ((c) and (d)), and IL-10 ((e) and (f)) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/e11ea648e3754f1c82da3860170303b5/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-2.jpg)
![Figure 3 Tempol inhibits KO2-induced COX-2 and preproET-1 mRNA expressions in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and COX-2 ((a) and (b)) and preproET-1 ((c) and (d)) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/ff6525b5a23442af85c66eed776511d4/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-3.jpg)
![Figure 4 Tempol inhibits KO2-induced depletion of antioxidant capacity in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2-stimulus and the oxidant capacity was evaluated by FRAP ((a) and (b)), ABTS ((c) and (d)), and GSH ((e) and (f)) assays. Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/19a0e66609774a44ae18c6bb97dcc962/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-4.jpg)
![Figure 5 Tempol inhibits KO2-induced oxidative stress in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2 injection to evaluate gp91phox mRNA expression ((a) and (b)) and NBT reduction (superoxide anion production assay, (c) and (d)) by qPCR and colorimetric assay, respectively. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/8abd4e8baa354d5094fdc52c21129055/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-5.jpg)
![Figure 6 Tempol inhibits KO2-induced decrease of Nrf2 mRNA expression in the paw skin and spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Paw skin and spinal cord samples were collected 3 h after KO2 injection and Nrf2 mRNA expression was evaluated by qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/d848ebc95a12449f887330fbb16c700b/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-6.jpg)
![Figure 7 Tempol inhibits KO2-induced astrocytes and microglia activation in the spinal cord. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before KO2 intraplantar injection. Spinal cord samples were collected 3 h after KO2 injection and GFAP (a) and Iba-1 (b) mRNA expressions were evaluated by RT-qPCR. Results were normalized using GAPDH as gene control and expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus KO2 + vehicle (one-way ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/82debfa8c81241feb6e1539960132cbb/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-7.jpg)
![Figure 8 Tempol inhibits carrageenan and complete Freund's adjuvant- (CFA-) induced hyperalgesia. Mice were treated with tempol (100 mg/kg) or vehicle 40 min before carrageenan or CFA intraplantar injection. Nociceptive thresholds to mechanical and thermal stimuli were measured 1–5 h after carrageenan injection (panels (a) and (b), resp.) and 1–7 days after CFA injection (panels (c) and (d), resp.). Results are expressed as means ± SEM (n = 6 per group per experiment, representative of two separate experiments) [∗p < 0.05 versus saline; #p < 0.05 versus carrageenan + vehicle for panels (a)-(b) and versus CFA + vehicle for panels (c)-(d) (ANOVA followed by Tukey's t-test)].](https://figures.cochat.ai/paper-figures/83e5f90e5e584a90b1354ab36adbdbba/tempol-a-superoxide-dismutase-mimetic-agent-inhibits-superoxide-anion-induced-figure-8.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However since O2●− is removed, its cellular role can be investigated with this substance [30,372].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [372]
In the citing paper
“Tempol (4-Hydroxy-Tempo) is a SOD mimetic and catalyzes the dismutation of O2●− into H2O2.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [372]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish
Niethammer, P., Grabher, C., Look, A. T., & Mitchison, T. J. (2009) · Nature · doi:10.1038/nature08119 · Cited by 1,541
Central sensitization and LTP: do pain and memory share similar mechanisms?
Ji, R.-R., Kohno, T., Moore, K. A., & Woolf, C. J. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.09.017 · Cited by 1,463
Nociceptor Sensory Neuron–Immune Interactions in Pain and Inflammation
Pinho-Ribeiro, F. A., Verri, W. A., & Chiu, I. M. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.10.001 · Cited by 1,027
Self-citationNeutrophils cascading their way to inflammation
Sadik, C. D., Kim, N. D., & Luster, A. D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.008 · Cited by 577
Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?
Verri, W. A., Cunha, T. M., Parada, C. A., Poole, S., Cunha, F. Q., & Ferreira, S. H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.001 · Cited by 542
Effects of tempol and redox-cycling nitroxides in models of oxidative stress
Wilcox, C. S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.003 · Cited by 465
A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma
Caceres, A. I., Brackmann, M., Elia, M. D., Bessac, B. F., del Camino, D., D'Amours, M., Witek, J. S., Fanger, C. M., Chong, J. A., Hayward, N. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900591106 · Cited by 463
An electronic pressure-meter nociception paw test for mice
Cunha, T. M., Verri Jr., W. A., Vivancos, G. G., Moreira, I. F., Reis, S., Parada, C. A., Cunha, F. Q., & Ferreira, S. H. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004000300018 · Cited by 459
TRPA1 is a major oxidant sensor in murine airway sensory neurons
Bessac, B. F., Sivula, M., von Hehn, C. A., Escalera, J., Cohn, L., & Jordt, S.-E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34192 · Cited by 449
A Newly Identified Role for Superoxide in Inflammatory Pain
Wang, Z.-Q., Porreca, F., Cuzzocrea, S., Galen, K., Lightfoot, R., Masini, E., Muscoli, C., Mollace, V., Ndengele, M., Ischiropoulos, H., et al. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064154 · Cited by 387
Research works printed but not linked: 4
- 2016, Frontiers in Pharmacology, 7, 532
- 1898, Journal of Biological Chemistry, 264, 11131
- 2016, PLoS ONE, 11
- 2016, PLoS ONE, 11
Cited by
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
Superoxide Dismutase Administration: A Review of Proposed Human Uses
Rosa, A. C., Corsi, D., Cavi, N., Bruni, N., & Dosio, F. (2021) · Molecules · doi:10.3390/molecules26071844 · Cited by 256
Superoxide dismutase and neurological disorders
Chidambaram, S. B., Anand, N., Varma, S. R., Ramamurthy, S., Vichitra, C., Sharma, A., Mahalakshmi, A. M., & Essa, M. M. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.11.007 · Cited by 174
Li, L., Guo, J., Wang, Y., Xiong, X., Tao, H., Li, J., Jia, Y., Hu, H., & Zhang, J. (2018) · Advanced Science · doi:10.1002/advs.201800781 · Cited by 160
Potential Therapeutic Applications of MnSODs and SOD‐Mimetics
Bonetta, R. (2018) · Chemistry – A European Journal · doi:10.1002/chem.201704561 · Cited by 134
Reactive Oxygen Species: Not Omnipresent but Important in Many Locations
Herb, M., Gluschko, A., & Schramm, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716406 · Cited by 87
Posadino, A. M., Giordo, R., Cossu, A., Nasrallah, G. K., Shaito, A. A., Abou-Saleh, H., Eid, A. H., & Pintus, G. (2019) · Biomolecules · doi:10.3390/biom9060209 · Cited by 84
de Souza, M., Baptista, A. A. S., Valdiviezo, M. J., Justino, L. G., Menck-Costa, M. F., Ferraz, C. R., da Glória, E. M., Verri, W. A., Jr., & Bracarense, A. P. F. R. L. (2020) · Toxicon · doi:10.1016/j.toxicon.2020.07.002 · Cited by 80
Extracellular superoxide dismutase (SOD3) regulates oxidative stress at the vitreoretinal interface
Wert, K. J., Velez, G., Cross, M. R., Wagner, B. A., Teoh-Fitzgerald, M. L. T., Buettner, G. R., McAnany, J. J., Olivier, A. K., Tsang, S. H., Harper, M. M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.024 · Cited by 59
Bussmann, A. J. C., Borghi, S. M., Zaninelli, T. H., Saraiva‐Santos, T., Guazelli, C. F. S., Fattori, V., Domiciano, T. P., Pinho-Ribeiro, F. A., Ruiz-Miyazawa, K. W., Casella, A., et al. (2019) · Inflammopharmacology · doi:10.1007/s10787-018-00561-6 · Cited by 35
Self-citationLourenco-Gonzalez, Y., Fattori, V., Domiciano, T. P., Rossaneis, A. C., Borghi, S. M., Zaninelli, T. H., Bernardy, C. C. F., Alves-Filho, J. C., Cunha, T. M., Cunha, F. Q., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/6481812 · Cited by 34
Self-citationSystemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl
Baby, S. M., Gruber, R. B., Discala, J. F., Puskovic, V., Jose, N., Cheng, F., Jenkins, M. W., Seckler, J. M., & Lewis, S. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.690407 · Cited by 29
López-Acosta, O., Fortis-Barrera, Á., Barrios-Maya, M. A., Ruiz‐Ramírez, A., Aguilar, F. J. A., & El‐Hafidi, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5835072 · Cited by 29
Baby, S. M., Discala, J. F., Gruber, R. B., Getsy, P. M., Cheng, F., Damron, D. S., & Lewis, S. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.749084 · Cited by 27
Direito, R., Rocha, J. P., Lima, A., Gonçalves, M. M., Duarte, M. P., Mateus, V., Sousa, A. C., Fernandes, A. M. A., Pinto, R. M. A., Ferreira, R. B., et al. (2019) · Medicines · doi:10.3390/medicines6020065 · Cited by 26
Tempol treatment shows phenotype improvement in mdx mice
Hermes, T. D. A., Mâncio, R. D., Macedo, A. B., Mizobuti, D. S., da Rocha, G. L., Cagnon, V. H. A., & Minatel, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215590 · Cited by 23
Ye, S., Xu, P., Huang, M., Chen, X., Zeng, S., Wang, Q., Chen, J., Li, K., Gao, W., Liu, R., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2499-8 · Cited by 23
Nonhormonal Treatment for Endometriosis Focusing on Redox Imbalance
Nagayasu, M., Imanaka, S., Kimura, M., Maruyama, S., & Kobayashi, H. (2021) · Gynecologic and Obstetric Investigation · doi:10.1159/000512628 · Cited by 21
Tempol improves redox status in mdx dystrophic diaphragm muscle
Hermes, T. D. A., Mizobuti, D. S., da Rocha, G. L., da Silva, H. N. M., Covatti, C., Pereira, E. C. L., Ferretti, R., & Minatel, E. (2020) · International Journal of Experimental Pathology · doi:10.1111/iep.12376 · Cited by 17
The Role of Oxidative Stress in Cocaine Addiction
Beiser, T., & Yaka, R. (2019) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2019/1.1239 · Cited by 17
Chacko, K. M., Nouri, M., Schramm, W. C., Malik, Z. S., Liu, L., Denslow, N. D., & Alli, A. A. (2021) · Biomolecules · doi:10.3390/biom11121804 · Cited by 17
Kinases in cerebral cavernous malformations: Pathogenesis and therapeutic targets
Qi, C., Bujaroski, R. S., Baell, J. B., & Zheng, X. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119488 · Cited by 14
Analgesic Effect of Methane Rich Saline in a Rat Model of Chronic Inflammatory Pain
Zhou, S., Zhou, Y., Ji, F., Li, H.-L., Hu, L., Zhang, Y., & Xu, H. X. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2490-2 · Cited by 14
Bianchini, B. H. S., Martelossi-Cebinelli, G., Carneiro, J. A., Rasquel-Oliveira, F. S., Casagrande, R., & Verri, W. A., Jr. (2025) · Future Pharmacology · doi:10.3390/futurepharmacol5040060 · Cited by 13
Self-citationNew advances in Nrf2-mediated analgesic drugs
Luan, Y., Luo, Y., & Deng, M. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154598 · Cited by 12
Afjal, M. A., Goswami, P., Ahmad, S., Dabeer, S., Akhter, J., Salman, M., Mangla, A., & Raisuddin, S. (2020) · Drug and Chemical Toxicology · doi:10.1080/01480545.2020.1831011 · Cited by 11
Dodds, K. N., Fattori, V., Andrews, N. A., Appleyard, C. B., Christianson, J. A., Gomez, R., McAllister, S. L., Missmer, S. A., Nagel, J., Nuñez‐Badinez, P., et al. (2025) · Molecular Human Reproduction · doi:10.1093/molehr/gaaf023 · Cited by 10
Self-citationVisible light triggers the formation of reactive oxygen species in monoclonal antibody formulations
Hipper, E., Diederichs, T., Kaiser, W., Lehmann, F., Buske, J., Hinderberger, D., & Garidel, P. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124392 · Cited by 8
Kumar, S., & Vinayak, M. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08609-z · Cited by 8
Zhang, Y., Tang, J., Li, N., Tao, J., Zhang, Y., Zhang, Y., Yang, Y., Zheng, Q., Xu, T., Liu, Y., et al. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.08.009 · Cited by 7
Martin, N., Chami, B., Vallejo, A., Mojadadi, A., Witting, P. K., & Ahmad, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094549 · Cited by 7
Danet, L., Guicheux, J., Boutet, M., & Vinatier, C. S. (2026) · Bone Research · doi:10.1038/s41413-026-00548-y · Cited by 6
Pothion, H., Lihrmann, I., Duclos, C., Riou, G., Cartier, D., Boukhzar, L., Lefranc, B., Leprince, J., Guérout, N., Marie, J., et al. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25098 · Cited by 6
Cyclodextrin‐Derived Macromolecular Therapies for Inflammatory Diseases
Tang, Y., Guo, T., Wang, X. D., Li, C., Zhang, X., & Zhang, J. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202400637 · Cited by 3
Targeted-Produced Dirhamnolipids from Pseudomonas aeruginosa Induce Antinociception in Mice
Wessel, K. B. B., Mello, A. P., Amador, I. R., Manchope, M. F., Morelli, N. R., Franciosi, A., Zaninelli, T. H., Bertozzi, M. M., Tischer, C. A., Martinez, R. M., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c03648 · Cited by 2
Self-citationPiva, M., Manchope, M. F., Barbosa-Costa, F., Bianchini, B. H. S., Andrade, K. C., Silva, L. F. D. R. S., Calixto-Campos, C., Rasquel-Oliveira, F. S., Fattori, V., Zarpelon-Schutz, A. C., et al. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s590675 · Cited by 2
Self-citationPreparation and properties of gelatin-tannic acid histidine metal complex microspheres
Jia, Q.-Q., Wang, Y., Huo, L., Wang, Y., & Jin, L. (2023) · European Polymer Journal · doi:10.1016/j.eurpolymj.2023.112318 · Cited by 2
[Effect of the chemoprotectant tempol on anti-tumor activity of cisplatin].
Ye, S., Zeng, S., Huang, M., Chen, J., Chen, X., Xu, P., Wang, Q., Gao, W., Yang, B., Hao, B., et al. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.08.02 · Cited by 2
Cirilo, M. A. D. S., SANTOS, V. B. S., Lima, N. K. S., Muzi‐Filho, H., Paixão, A. D. O., Vieyra, A. R., & Filho, L. D. V. (2024) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202420230971 · Cited by 2
Bussmann, A. J. D. C. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Artero, N. A. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Carneiro, J. A., Bianchini, B. H. S., Martelossi-Cebinelli, G., Artero, N. A., Maximiano, T. K. E., Franciosi, A., Dionisio, A. M., Yaekashi, K. M., de Carvalho, T. T., da Silva, M. D. V., et al. (2026) · Inflammation Research · doi:10.1007/s00011-026-02234-5
Self-citationTimbury, W., Gettings, S. M., Shek, R., Lindsay, C. D., Sharma, R., Najim, M., & Bourbia, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.11.735255
Manodara, G. (2024) · OPUS - Open Publications of UTS Scholars (University of Technology Sydney)
Metadata
- Authors
- Bernardy, C. C. F., Zarpelon, A. C., Pinho-Ribeiro, F. A., Calixto-Campos, C., Carvalho, T. T., Fattori, V., Borghi, S. M., Casagrande, R., & Verri, W. A.
- Affiliations
- Department of Nursing, Health Science Centre, State University of Londrina, Londrina, PR, Brazil
- Universidade Estadual de Londrina (BR)
- Department of Pathology, Biological Science Centre, State University of Londrina, Londrina, PR, Brazil
- Department of Pharmaceutical Sciences, Health Science Centre, State University of Londrina, Londrina, PR, Brazil
- ORCID
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-15
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC5446866
- OpenAlex
- W2613348303
- Cited by
- 40
- References
- 52
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 9 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 1
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Ministério da Ciência Tecnologia e Inovação
- Secretaria da Ciência, Tecnologia e Ensino Superior
- Fundação Araucária
- Parana State Government
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- tempol, superoxide dismutase mimetic, inflammatory pain, superoxide, potassium superoxide, oxidative stress, Nrf2, mechanical hyperalgesia, thermal hyperalgesia, paw edema, glial activation, TNF-α, IL-1β, IL-10, cyclooxygenase-2, endothelin-1, gp91phox, carrageenan-induced inflammation, complete Freund's adjuvant, analgesics, anti-inflammatory agents
- MeSH terms
- NADPH Oxidase 2, Animals, Calcium-Binding Proteins, Cyclic N-Oxides, Glial Fibrillary Acidic Protein, Male, Mice, Inbred BALB C, Microfilament Proteins, Pain, Spin Labels, Superoxides, Superoxide Dismutase, Cytokines, Biomimetic Materials, NF-E2-Related Factor 2, Mice, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.